CClinicalTrials.gg
Status unknownNCT05846061Updated May 6, 2023

Epidemiology of Helicobacter Pylori Infection in Children From Slovenia

An observational study in Helicobacter Pylori Infection and Transmission, sponsored by University Medical Centre Ljubljana. Status unknown at 1 site in Slovenia. Open to participants aged 5 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-06.

Sponsored by University Medical Centre Ljubljana · Observational

The sponsor has not verified this record recently (last verified Apr 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
430
Ages
5 Years to 18 Years
Sex
All
01

Study summary

The epidemiology of H. pylori infection among children in Slovenia has not been investigated. Therefore, we are conducting a study to examine the epidemiology of H. pylori and associated risk factors among children in Slovenia.

Read the detailed description

The population selection was from the three different geographic location in Slovenia. The selection of the studied places was based on their social and economic characteristics and medical provision. We included children from three age groups at the same time we collected information from the parents which may be important for H. pylori transmission.

02

Conditions studied

  • Helicobacter Pylori Infection
  • Transmission

Keywords

  • children
  • infection
03

In context

Infections

6,687 studies on the registry are indexed under Infections; 807 are open to participants now.

This study's planned enrollment of 430 is above the median of 240 across 2,136 observational studies indexed under Infections.

Browse Infections studies →

Lead sponsor

University Medical Centre Ljubljana is the lead sponsor of 284 studies on the registry; 71 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

children from school of different age groups- community sample

Inclusion criteria

  • age 6, 14 and 17 years living in three different regions in Slovenia

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
430 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Prevalence study population

    prevalence study population

    Other: Prevalence study population

Interventions

  • OtherPrevalence study population

    No intervention

06

What researchers measure

Primary outcomes

  1. The number of infected children in different age population

    Time frame: 3 years

07

Study locations

1 of 1 sites recruiting
  • University Children's Hospital in Ljubljana
    Ljubljana, 1000, Slovenia
    • Matjaz Homan, MD PhD · Contact · matjaz.homan@guest.arnes.si · 0038640885848
    • Nusa Cesar, MD · Contact · nusa.cesar@gmai.com · 0038615229276
    • Polona Maver Vodičar, MD PhD · Sub investigator
    • Saša Simšič, MD PhD · Sub investigator
    • Eva Mojškrc, MD · Sub investigator
    Recruiting
08

References and documents

Publications

  • Polivanova TV, Malaty H, Vshivkov VA. Epidemiology Helicobacter pylori infection in children in the Tyva Republic (Russia). Helicobacter. 2022 Jun;27(3):e12882. doi: 10.1111/hel.12882. Epub 2022 Mar 13. PubMed 35285106 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05846061
Lead sponsor
University Medical Centre Ljubljana
Responsible party
Tadej Battelino (Professor of paediatrics, University Medical Centre Ljubljana) — Principal investigator
First posted
May 6, 2023
Start date
Jan 9, 2021
Primary completion
Jan 9, 2023
Completion
Jun 9, 2023 (estimated)
Last update
May 6, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion